Product Name:Tesamorelin,Egrifta
CAS NO.:218949-48-5
Molecular Formula:C221H366N72O67S
Molecular Weight:5135.9

Tesamorelin (INN) (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. It is produced and developed by Theratechnologies, Inc. of Canada.